Oakbrook Investments’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-5,400
Closed -$318K 265
2019
Q4
$318K Buy
+5,400
New +$293K 0.06% 451
2019
Q3
Sell
-5,400
Closed -$228K 616
2019
Q2
$228K Buy
5,400
+300
+6% +$13K 0.01% 550
2019
Q1
$252K Buy
5,100
+100
+2% +$4.52K 0.02% 535
2018
Q4
$216K Sell
5,000
-500
-9% -$24.9K 0.01% 534
2018
Q3
$312K Sell
5,500
-100
-2% -$5.26K 0.02% 541
2018
Q2
$283K Buy
5,600
+100
+2% +$5.21K 0.02% 474
2018
Q1
$274K Buy
+5,500
New +$259K 0.02% 491

Other funds holding GMED

Oakbrook Investments's GMED Position: Q1 2020 in Review

Oakbrook Investments sold out of Globus Medical (GMED) in Q1 2020, closing a stake of 5,400 shares — an estimated $318K sold.

Oakbrook Investments first reported a position in GMED in Q1 2018 and held it in 7 quarters. The position peaked at $318K in Q4 2019. 273 funds tracked by Wall St. Rank hold GMED as of Q1 2020.

  • Oakbrook Investments reported no remaining Globus Medical position as of Q1 2020 after selling out during the quarter.
  • Oakbrook Investments sold 5,400 Globus Medical shares in Q1 2020, an estimated $318K.
  • Oakbrook Investments first reported a position in Globus Medical in Q1 2018 and held it in 7 quarters.
  • Oakbrook Investments's Globus Medical position peaked at $318K in Q4 2019.
  • 273 funds tracked by Wall St. Rank held Globus Medical as of Q1 2020.

Based on Oakbrook Investments's 13F filing for Q1 2020, filed 22 Apr 2020.